[Macro-CK type 1: a methodological study approach and its clinical significance].
Description of an analytical procedure in order to show the atypical-CK carriers that simulate an abnormal raising of CK-MB circulating levels in dosages for immune inhibition. This procedure was applied to two samples taken from patients of such a type, immune form neoplastic and cardiac pathology. A systematic dosage of a "real" MB isoenzyme is desirable in all the cases of very raised CK-MB activity.
Soffritti
E
E
Laboratorio di analisi cliniche, U.S.L. 34, Copparo, Ferrara.
Ferrari
R
R
Bernardoni
R
R
Pelizzola
D
D
Rocchi
L
L
D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis; D000936:Antigen-Antibody Complex / Q000032:analysis; D002852:Chromatography, Ion Exchange / Q000379:methods; D004796:Clinical Enzyme Tests / Q000379:methods*; D003402:Creatine Kinase / Q000097:blood* / Q000276:immunology; D004588:Electrophoresis, Cellulose Acetate / Q000379:methods; D005260:Female; D006801:Humans; D007527:Isoenzymes; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis
D000906:Antibodies; D000936:Antigen-Antibody Complex; D007527:Isoenzymes; D003402:Creatine Kinase
Macro-CK tipo 1: approccio metodologico di indagine e suo significato clinico.